Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
NCT02854969 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2017-07-26
Summary
Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.
Conditions
Interventions
- BEHAVIORAL
-
Device: Anapphylaxis
Sponsors & Collaborators
-
Adan Medical Innovation, SL
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-07-18
- Completion
- 2017-07-18
Countries
- Spain
Study Locations
More Related Trials
-
Study of Mepolizumab Safety Syringe in Asthmatics
NCT03021304 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
NCT00358449 ·Status: COMPLETED ·Phase: PHASE2
-
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
NCT06369467 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor
NCT04444895 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
NCT01912456 ·Status: COMPLETED ·Phase: PHASE3
-
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
NCT02635776 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
NCT04056299 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
NCT00890162 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
NCT07266805 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
NCT07046806 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN
NCT03203369 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects
NCT03070561 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
NCT01904604 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug
NCT03014674 ·Status: COMPLETED ·Phase: PHASE3
-
PALISADE Follow-on Study (ARC004)
NCT02993107 ·Status: COMPLETED ·Phase: PHASE3
-
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
NCT04681729 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
NCT01170286 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
NCT07287033 ·Status: RECRUITING ·Phase: PHASE1
-
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
NCT01264939 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
NCT02810444 ·Status: COMPLETED ·Phase: PHASE3
-
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
NCT03292484 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
NCT02841995 ·Status: COMPLETED ·Phase: PHASE2
-
B Cell Induction in Pediatric Lung Transplantation
NCT02266888 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy for Peanut Allergy
NCT00429429 ·Status: COMPLETED ·Phase: NA
-
Effect of Anti-IgE in Chronic Urticaria
NCT00130234 ·Status: COMPLETED ·Phase: PHASE2